Elsevier

Resuscitation

Volume 85, Issue 12, December 2014, Pages 1686-1691
Resuscitation

Clinical Paper
HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): A randomised controlled feasibility trial

https://doi.org/10.1016/j.resuscitation.2014.09.011Get rights and content

Abstract

Aims

To investigate the feasibility of delivering titrated oxygen therapy to adults with return of spontaneous circulation (ROSC) following out-of-hospital cardiac arrest (OHCA) caused by ventricular fibrillation (VF) or ventricular tachycardia (VT).

Methods

We used a multicentre, randomised, single blind, parallel groups design to compare titrated and standard oxygen therapy in adults resuscitated from VF/VT OHCA. The intervention commenced in the community following ROSC and was maintained in the emergency department and the Intensive Care Unit. The primary end point was the median oxygen saturation by pulse oximetry (SpO2) in the pre-hospital period.

Results

159 OHCA patients were screened and 18 were randomised. 17 participants were analysed: nine in the standard care group and eight in the titrated oxygen group. In the pre-hospital period, SpO2 measurements were lower in the titrated oxygen therapy group than the standard care group (difference in medians 11.3%; 95% CI 1.0–20.5%). Low measured oxygen saturation (SpO2 < 88%) occurred in 7/8 of patients in the titrated oxygen group and 3/9 of patients in the standard care group (P = 0.05). Following hospital admission, good separation of oxygen exposure between the groups was achieved without a significant increase in hypoxia events. The trial was terminated because accumulated data led the Data Safety Monitoring Board and Management Committee to conclude that safe delivery of titrated oxygen therapy in the pre-hospital period was not feasible.

Conclusions

Titration of oxygen in the pre-hospital period following OHCA was not feasible; it may be feasible to titrate oxygen safely after arrival in hospital.

Introduction

Despite oxygen being a ubiquitous therapy in patients resuscitated from out-of-hospital cardiac arrest (OHCA), there is little high quality evidence to guide clinicians about how best to use oxygen in this patient group. With the exception of one pilot trial,1 no previous prospective study of different oxygen regimens following resuscitation from OHCA has been performed. There is a sound scientific basis supporting the hypothesis that avoidance of hyperoxia after resuscitation from OHCA might reduce neurological injury.2 On the other hand, although exposure to hyperoxia appears to be associated with increased in-hospital mortality in observational studies,3, 4, 5 significant heterogeneity in the results of the existing studies means that there is uncertainty about this association.6 Furthermore, even if the association proved to be robust, it is possible that arterial hyperoxia is a marker of illness severity rather than a determinant of outcome.7 For example, the presence of poor peripheral perfusion could potentially lead clinicians to increase the inspired oxygen concentration (FiO2) on the basis of spuriously low peripheral pulse oximetry (SpO2) recordings. Moreover, even if hyperoxia were truly harmful, any attempt to reduce oxygen exposure in post-resuscitation management may carry with it the potential risk of exposing patients to hypoxia which is also consistently associated with increased mortality risk.4, 7

As a result of the current uncertainty, a high quality prospective trial evaluating the effect of titrated oxygen therapy on patient outcomes after OHCA is a research priority.8 With the eventual objective of conducting such a trial, we undertook a feasibility study to evaluate whether or not an individualised oxygen titration regimen designed to limit exposure to hyperoxia in patients with return of spontaneous circulation (ROSC) after OHCA led to an effective reduction in oxygen exposure compared to standard care without exposing patients to a greater incidence and severity of hypoxia.

Section snippets

Trial design and setting

We performed a prospective, multi-centre, single-blind, parallel-groups, feasibility and safety randomised controlled trial (RCT) comparing titrated oxygen administration to standard care with high concentration oxygen in adults resuscitated from OHCA. This trial was conducted in New Zealand. We intended to enrol patients in Auckland, Christchurch, the Hutt Valley, and Wellington. However, at the time the trial was terminated, site initiation had not been completed in Auckland or Christchurch

Participants

Between 13/10/2012 and 21/09/2013 159 cardiac arrests were screened and 18 participants were randomised (Fig. 1). One non-eligible patient was randomised but received no study treatment and was not included in the analyses. Data for the primary end point were available for the other 17 participants. The trial was terminated early because ongoing review of accumulated data led the Data Safety Monitoring Board and the study management committee to conclude that safe delivery of titrated oxygen

Summary of principal findings

We conducted a multicentre feasibility study comparing titrated oxygen therapy to standard oxygen therapy in patients resuscitated from OHCA in New Zealand. The study was stopped early because preliminary data strongly suggested that our approach to delivering titrated oxygen therapy in the pre-hospital setting was not feasible. While targeting an SpO2 of 90–94% achieved significantly lower SpO2 measurements than standard care in the pre-hospital period, SpO2 recordings varied widely,

Conclusions

Titration of oxygen delivery to SpO2 following resuscitation from OHCA was not feasible in the pre-hospital setting. However, our preliminary data suggest that it may be possible to titrate oxygen after arrival in hospital. The safety and efficacy of any strategy to reduce oxygen exposure in hospital in OHCA patients should be further evaluated through prospective trials.

Conflicts of interest statement

The authors have no conflicts of interest to report.

Funding

This study was an investigator-initiated study funded by a Feasibility Grant provided by the Health Research Council of New Zealand (13/666). The study was conducted independently of the funder.

Acknowledgements

The authors would like to acknowledge the support for this study provided by the staff of Wellington Free Ambulance, St John Ambulance, Hutt Valley District Health Board, and Capital Coast District Health Board.

References (14)

There are more references available in the full text version of this article.

Cited by (78)

View all citing articles on Scopus

A Spanish translated version of the summary of this article appears as Appendix in the final online version at http://dx.doi.org/10.1016/j.resuscitation.2014.09.011.

View full text